Learn about the clinical trials INTEGRIS Health Advanced Cardiopulmonary Care is involved with.
If you have a potential patient who may meet the criteria for a clinical trial, we encourage you to contact our Clinical Research Manager.
Name: Kristin Mund
Email: [email protected]
| NCT03384875 2017-001 REFRESH II Trial | “CytoSorb® Reduction of FREe Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery (REFRESH II Trial)” |
| NCT02892955 MOMENTUM 3 CAP | “MOMENTUM 3 CAP Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy with HeartMate 3™ Continued Access Protocol” |
| NCT02232659 | “SynCardia 70cc Temporary Total Artificial Heart (TAH-t) for Destination Therapy (DT)” |
| NCT02554903 AC-055-205 SOPRANO | “A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Macitentan in Patients with Pulmonary Hypertension after Left Ventricular Assist Device Implantation” |
| NCT02861534 1242-001 VICTORIA | “A Randomized Parallel-Group, Placebo-Controlled, Double-Blind, Event-Driven, Multi-Center Pivotal Phase III Clinical Outcome Trial of Efficacy and Safety of the Oral sGC Stimulator Vericiguat in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF) - Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA)” |
| NCT02816736 HFN-LIFE | “EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)” |
| NCT03387813 CIP-10170 GUIDE-HF | “Hemodynamic-GUIDEd Management of Heart Failure” |
| NCT02030418 DC-02374 | “Safety and Effectiveness Trial for the Nanostim Leadless Pacemaker” |
